In response to research published in JAMA Open Network about the benefits of exercise for women recovering from breast cancer, Dr Kotryna Temcinaite...

18 November 2022

In response to research presented at the 13th European Breast Cancer Conference about radiotherapy and long-term survival,  Dr Kotryna...

18 November 2022

  In response to research presented at the 13th European Breast Cancer Conference that showed women who have benign breast conditions,...

17 November 2022

Repsonding, Melanie Sturtevant, Associate Director for Policy, Evidence and Influencing at Breast Cancer Now, said:   “This morning’s...

11 November 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s devastating that olaparib - a ground-breaking and...

10 November 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said: “It’s fantastic news that immunotherapy pembrolizumab has been...

8 November 2022

Breast Cancer Now is calling for the Faster Diagnosis Standard to be a symbol of recovery, as the charity warns of too many missed opportunities to...

13 October 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Today’s approval of pembrolizumab (Keytruda) in combination with...

10 October 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "Today's approval of palbociclib with fulvestrant for routine use...

23 September 2022